Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 1,000
- Primary Endpoint
- Fabry disease
Study Overview
Brief Summary
Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients
Detailed Description
This is a cross-sectional, population-based study. No randomization procedure will be executed in this study. Approximately 1000 subjects over a 36-month period. The aim of this screening study is to identify the Fabry disease as the cause in patients with young stroke.
To measure the level of α-Gal A activity, male subjects will initially provide a DBS sample and female subjects will start with a test by whole blood sample.
The prevalence of Fabry disease among patients with young stroke will be estimated by a confirmative diagnosis in gene testing.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 20 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients aged 20 or over
- •Patients aged under 56 years old, not included 56
- •Patients with acute stroke
- •Patients and/or their legal representatives are willing to provide written informed consent
Exclusion Criteria
- •Patients with a confirmed diagnosis of Fabry disease
Outcomes
Primary Outcomes
Fabry disease
Time Frame: 3 years later
The prevalence of Fabry disease in patients with young stroke
Secondary Outcomes
No secondary outcomes reported